Physician profile
Roger Williams
NPI 1174543821
$10,290.59
in general payments reported to CMS, 2019-2025
28 companies · $469 in 2025
The $469 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $177 · 2021: $566 · 2022: $474 · 2023: $5,951 · 2024: $2,285 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,284 · Food and Beverage: $3,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,284.34 |
| Food and Beverage | $3,420.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $6,924.02 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $971.56 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $898.41 | 2019-2024 | Myrbetriq, Veozah |
| Urovant Sciences INC | $277.32 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $270.41 | 2019-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $130.30 | 2020-2025 | Axonics, Lithovue |
| Janssen Biotech, INC. | $100.02 | 2020-2024 | Erleada |
| Abbvie INC. | $95.10 | 2019-2025 | |
| Endo USA, INC. | $69.05 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $64.99 | 2021-2025 | Interstim |
| Rochester Medical Corporation | $49.36 | 2019-2022 | |
| Halozyme INC | $44.41 | 2023 | |
| Procept Biorobotics Corporation | $42.73 | 2023-2025 | Aquabeam Robotic System |
| Antares Pharma, INC. | $40.68 | 2023 | Xyosted, Nocdurna, Tlando |
| Tolmar, INC. | $31.07 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $30.14 | 2020-2021 | |
| Telix Pharmaceuticals | $29.27 | 2025 | Illuccix |
| Olympus America INC. | $27.14 | 2021 | |
| Convatec INC. | $26.73 | 2021 | |
| Teleflex LLC | $25.54 | 2025 | Barrigel |
| Ferring Pharmaceuticals INC. | $23.54 | 2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $19.98 | 2024 | Bard Urinary Drainage Bag |
| Novartis Pharmaceuticals Corporation | $19.38 | 2025 | |
| Urogen Pharma, INC. | $18.56 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.28 | 2023 | Prolaris |
| Steris Corporation | $16.06 | 2024 | |
| Immunitybio, INC. | $15.23 | 2025 | |
| Conmed Corporation | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.